Target intelligence / Profile preview

Fibrin formation via exogenous human fibrinogen and bovine thrombin (N/A)

Target: N/A
Molecular classification: Enzyme Cascade, Hemostatic Agent

Overview

Fibrin formation at a wound site achieved by the application of exogenous human fibrinogen and bovine thrombin. Thrombin cleaves fibrinogen, leading to fibrin monomer polymerization and clot formation. This provides immediate hemostasis, acts as a physical barrier against infection, and influences local proteolytic activity via PAI-1.

Other names: Exogenous Fibrin Clot FormationFibrin Sealant ApplicationTissue Adhesive ApplicationTopical Hemostasis with Fibrinogen and Thrombin

Mechanism of action

Thrombin cleaves fibrinogen to form fibrin monomers, which polymerize into a fibrin clot, providing hemostasis and a physical barrier at the wound site.

Biological functions

HemostasisWound HealingTissue SealingBarrier to InfectionRegulation of Proteolysis

Disease associations

HemorrhageSurgical BleedingWound ManagementTissue Repair

Safety considerations

Risk of viral transmission (though minimized with modern production methods)Risk of allergic reaction to bovine thrombin or human fibrinogenPotential for thrombosis if used excessively or inappropriatelyInfection risk if not applied under sterile conditions

Interacting drugs

Human Fibrinogen

3 more in the full profile.

Biomarkers

Fibrinogen levels (pre-operative assessment)Thrombin time (pre-operative assessment)Platelet count (pre-operative assessment)

Beyond the preview

Go deeper on Fibrin formation via exogenous human fibrinogen and bovine thrombin (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibrin formation via exogenous human fibrinogen and bovine thrombin (N/A).

Explore the full profile